{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:24:25Z","timestamp":1793388265636,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:00:00Z","timestamp":1614988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:00:00Z","timestamp":1614988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007684","name":"Asahi Glass Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100007684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12035-021-02343-8","type":"journal-article","created":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T15:02:31Z","timestamp":1615042951000},"page":"3319-3334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-871X","authenticated-orcid":false,"given":"Michael","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristo","family":"Vojdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunee","family":"Sirivichayakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decio S.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buranee","family":"Kanchanatawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,6]]},"reference":[{"issue":"9","key":"2343_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/brainsci10090645","volume":"10","author":"M Maes","year":"2020","unstructured":"Maes M, Vojdani A, Galecki P, Kanchanatawan B (2020) How to construct a bottom-up nomothetic network model and disclose novel nosological classes by integrating risk resilience and adverse outcome pathways with the phenome of schizophrenia. Brain Sci 10(9):645. https:\/\/doi.org\/10.3390\/brainsci10090645","journal-title":"Brain Sci"},{"key":"2343_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1092852920001182","volume":"20","author":"AF Almulla","year":"2020","unstructured":"Almulla AF, Al-Hakeim HK, Maes M (2020) Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia. CNS Spectr 20:1\u201310. https:\/\/doi.org\/10.1017\/S1092852920001182 Epub ahead of print","journal-title":"CNS Spectr"},{"issue":"1","key":"2343_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1515\/bmc-2019-0023","volume":"10","author":"M Maes","year":"2019","unstructured":"Maes M, Vojdani A, Geffard M, Moreira EG, Barbosa DS, Michelin AP, Seme\u00e3o LO, Sirivichayakul S et al (2019) Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways. Biomol Concepts 10(1):209\u2013225","journal-title":"Biomol Concepts"},{"key":"2343_CR4","doi-asserted-by":"publisher","unstructured":"Maes M, Kanchanatawan B (2020) A generalized cognitive decline (GCoDe) partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and lowered quality of life in (deficit) schizophrenia. Preprints 2020110523 https:\/\/doi.org\/10.20944\/preprints202011.0523.v1.","DOI":"10.20944\/preprints202011.0523.v1"},{"issue":"1","key":"2343_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11011-018-0339-7","volume":"34","author":"B Kanchanatawan","year":"2019","unstructured":"Kanchanatawan B, Sriswasdi S, Maes M (2019) Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia. Metab Brain Dis 34(1):267\u2013282. https:\/\/doi.org\/10.1007\/s11011-018-0339-7","journal-title":"Metab Brain Dis"},{"issue":"Pt C","key":"2343_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.pnpbp.2017.06.031","volume":"80","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Thika S, Anderson G, Galecki P, Maes M (2018) Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition. Prog Neuro-Psychopharmacol Biol Psychiatry 80(Pt C):168\u2013176","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"11","key":"2343_CR7","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1007\/s12035-020-02047-5","volume":"57","author":"M Maes","year":"2020","unstructured":"Maes M, Sirivichayakul S, Matsumoto AK, Michelin AP, de Oliveira SL, de Lima Pedr\u00e3o JV, Moreira EG, Barbosa DS et al (2020) Lowered antioxidant defenses and increased oxidative toxicity are hallmarks of deficit schizophrenia: a nomothetic network psychiatry approach. Mol Neurobiol 57(11):4578\u20134597","journal-title":"Mol Neurobiol"},{"key":"2343_CR8","unstructured":"CANTAB (2018) The most validated cognitive research software. http:\/\/www.cambridgecognition.com\/cantab\/ October 1, 2018."},{"key":"2343_CR9","unstructured":"CERAD (1986) CERAD \u2013 An overview: the consortium to establish a registry for Alzheimer\u2019s disease. 1986; http:\/\/cerad.mc.duke.edu\/"},{"issue":"6","key":"2343_CR10","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1007\/s12035-017-0751-8","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Hemrungrojn S, Thika S, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G et al (2018) Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia. Mol Neurobiol 55(6):5184\u20135201","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2343_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF00435734","volume":"2","author":"WHO","year":"1993","unstructured":"WHO (1993) Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res 2(2):153\u2013159","journal-title":"Qual Life Res"},{"issue":"4","key":"2343_CR12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s11011-018-0208-4","volume":"33","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Sriswasdi S, Thika S, Sirivichayakul S, Carvalho AF, Geffard M, Kubera M, Maes M (2018) Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning. Metab Brain Dis 33(4):1053\u20131067","journal-title":"Metab Brain Dis"},{"issue":"4","key":"2343_CR13","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/jep.12945","volume":"24","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Sriswasdi S, Thika S, Stoyanov D, Sirivichayakul S, Carvalho AF, Geffard M, Maes M (2018) Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: results of unsupervised machine learning analysis. J Eval Clin Pract 24(4):879\u2013891","journal-title":"J Eval Clin Pract"},{"issue":"6","key":"2343_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/1871527317666180702160921","volume":"17","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Maes M (2018) The effects of tryptophan catabolites on negative symptoms and deficit schizophrenia are partly mediated by executive impairments: results of partial least squares path modeling. CNS Neurol Disord Drug Targets 17(6):473\u2013486","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"2","key":"2343_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0165-1781(89)90153-4","volume":"30","author":"B Kirkpatrick","year":"1989","unstructured":"Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30(2):119\u2013123","journal-title":"Psychiatry Res"},{"issue":"2","key":"2343_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0306-9877(95)90062-4","volume":"45","author":"RS Smith","year":"1995","unstructured":"Smith RS, Maes M (1995) The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses 45(2):135\u2013141. https:\/\/doi.org\/10.1016\/0306-9877(95)90062-4","journal-title":"Med Hypotheses"},{"issue":"1","key":"2343_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0165-1781(96)02915-0","volume":"66","author":"M Maes","year":"1997","unstructured":"Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharp\u00e9 S (1997) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 66(1):1\u201311. https:\/\/doi.org\/10.1016\/s0165-1781(96)02915-0","journal-title":"Psychiatry Res"},{"issue":"2","key":"2343_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s12035-019-01737-z","volume":"57","author":"C Roomruangwong","year":"2020","unstructured":"Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF, Maes M (2020) The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia. Mol Neurobiol 57(2):778\u2013797. https:\/\/doi.org\/10.1007\/s12035-019-01737-z Epub 2019 Aug 31","journal-title":"Mol Neurobiol"},{"issue":"5","key":"2343_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","volume":"89","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Bosmans E (1994) Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 89(5):346\u2013351. https:\/\/doi.org\/10.1111\/j.1600-0447.1994.tb01527.x","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"2343_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF02190412","volume":"244","author":"M Maes","year":"1995","unstructured":"Maes M, Meltzer HY, Buckley P, Bosmans E (1995) Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression. Eur Arch Psychiatry Clin Neurosci 244(6):325\u2013329. https:\/\/doi.org\/10.1007\/BF02190412","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"2343_CR21","doi-asserted-by":"publisher","first-page":"pyu042","DOI":"10.1093\/ijnp\/pyu042","volume":"18","author":"C Noto","year":"2014","unstructured":"Noto C, Ota VK, Gouvea ES, Rizzo LB, Spindola LM, Honda PH, Cordeiro Q, Belangero SI et al (2014) Effects of risperidone on cytokine profile in drug-na\u00efve first-episode psychosis. Int J Neuropsychopharmacol 18(4):pyu042. https:\/\/doi.org\/10.1093\/ijnp\/pyu042","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"2343_CR22","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s12035-020-01882-w","volume":"57","author":"M Maes","year":"2020","unstructured":"Maes M, Sirivichayakul S, Matsumoto AK, Maes A, Michelin AP, de Oliveira SL, de Lima Pedr\u00e3o JV, Moreira EG et al (2020) Increased levels of plasma tumor necrosis factor-\u03b1 mediate schizophrenia symptom dimensions and neurocognitive impairments and are inversely associated with natural IgM directed to malondialdehyde and paraoxonase 1 activity. Mol Neurobiol 57(5):2333\u20132345. https:\/\/doi.org\/10.1007\/s12035-020-01882-w Epub 2020 Feb 10","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2343_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12640-018-9937-8","volume":"35","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M (2019) Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients. Neurotox Res 35(1):122\u2013138","journal-title":"Neurotox Res"},{"issue":"2","key":"2343_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/1871527317666181119115532","volume":"18","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M (2019) A new schizophrenia model: immune activation is associated with the induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions. CNS Neurol Disord Drug Targets 18(2):124\u2013140","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"10","key":"2343_CR25","doi-asserted-by":"publisher","first-page":"7056","DOI":"10.1007\/s12035-019-1578-2","volume":"56","author":"M Maes","year":"2019","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A (2019) Upregulation of the intestinal paracellular pathway with breakdown of tight and adherens junctions in deficit schizophrenia. Mol Neurobiol 56(10):7056\u20137073. https:\/\/doi.org\/10.1007\/s12035-019-1578-2 Epub 2019 Apr 10","journal-title":"Mol Neurobiol"},{"key":"2343_CR26","doi-asserted-by":"publisher","first-page":"113467","DOI":"10.1016\/j.psychres.2020.113467","volume":"293","author":"W Guidara","year":"2020","unstructured":"Guidara W, Messedi M, Naifar M, Maalej M, Grayaa S, Omri S, Ben Thabet J, Maalej M et al (2020) Predictive value of oxidative stress biomarkers in drug-free patients with schizophrenia and schizo-affective disorder. Psychiatry Res 293:113467. https:\/\/doi.org\/10.1016\/j.psychres.2020.113467 Epub 2020 Sep 20","journal-title":"Psychiatry Res"},{"issue":"7","key":"2343_CR27","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1007\/s12035-018-1437-6","volume":"56","author":"M Maes","year":"2019","unstructured":"Maes M, Kanchanatawan B, Sirivichayakul S (2019) Carvalho AF (2019) In schizophrenia, deficits in natural IgM isotype antibodies including those directed to malondialdehyde and azelaic acid strongly predict negative symptoms, neurocognitive impairments, and the deficit syndrome. Mol Neurobiol 56(7):5122\u20135135. https:\/\/doi.org\/10.1007\/s12035-018-1437-6 Epub 2018 Nov 27","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2343_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12640-019-00054-6","volume":"36","author":"M Maes","year":"2019","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A (2019) Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit schizophrenia. Neurotox Res 36(2):306\u2013322","journal-title":"Neurotox Res"},{"issue":"3","key":"2343_CR29","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.euroneuro.2018.12.008","volume":"29","author":"MN Noto","year":"2019","unstructured":"Noto MN, Maes M, Nunes SOV, Ota VK, Rossaneis AC, Verri WA Jr, Cordeiro Q, Belangero SI et al (2019) Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis. Eur Neuropsychopharmacol 29(3):416\u2013431. https:\/\/doi.org\/10.1016\/j.euroneuro.2018.12.008 Epub 2018 Dec 26","journal-title":"Eur Neuropsychopharmacol"},{"issue":"11","key":"2343_CR30","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.3390\/jcm9113707","volume":"9","author":"M Dzikowski","year":"2020","unstructured":"Dzikowski M, Juchnowicz D, Dzikowska I, Rog J, Pr\u00f3chnicki M, Kozio\u0142 M, Karakula-Juchnowicz H (2020) The differences between gluten sensitivity, intestinal biomarkers and immune biomarkers in patients with first episode and chronic schizophrenia. J Clin Med 9(11):3707. https:\/\/doi.org\/10.3390\/jcm9113707","journal-title":"J Clin Med"},{"key":"2343_CR31","unstructured":"Kittirathanapaiboon P, Khamwongpin M (2005) The validity of the mini international neuropsychiatric interview (M.I.N.I.) Thai version: Suanprung Hospital, Department of Mental Health."},{"issue":"2","key":"2343_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0165-1781(86)90011-9","volume":"19","author":"SR Kay","year":"1986","unstructured":"Kay SR, Fiszbein A, Opler LA (1986) Negative symptom rating scale: limitations in psychometric and research methodology. Psychiatry Res 19(2):169\u2013173","journal-title":"Psychiatry Res"},{"key":"2343_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1192\/S0007125000291496","volume":"7","author":"NC Andreasen","year":"1989","unstructured":"Andreasen NC (1989) The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations. Brit J Psychiatry Suppl 7:49\u201358","journal-title":"Brit J Psychiatry Suppl"},{"key":"2343_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799\u2013812","journal-title":"Psychol Rep"},{"key":"2343_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2343_CR36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1017\/neu.2019.30","volume":"31","author":"C Roomruangwong","year":"2019","unstructured":"Roomruangwong C, Carvalho AF, Geffard M, Maes M (2019) The menstrual cycle may not be limited to the endometrium but also may impact gut permeability. Acta Neuropsychiatr 31(6):294\u2013304. https:\/\/doi.org\/10.1017\/neu.2019.30","journal-title":"Acta Neuropsychiatr"},{"key":"2343_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statistics Soc Series b (Methodological) 57:289\u2013300","journal-title":"J Royal Statistics Soc Series b (Methodological)"},{"issue":"3","key":"2343_CR38","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/schbul\/sbi017","volume":"31","author":"K Rosen","year":"2005","unstructured":"Rosen K, Garety P (2005) Predicting recovery from schizophrenia: a retrospective comparison of characteristics at onset of people with single and multiple episodes. Schizophr Bull 31(3):735\u2013750. https:\/\/doi.org\/10.1093\/schbul\/sbi017 Epub 2005 Feb 16","journal-title":"Schizophr Bull"},{"issue":"4","key":"2343_CR39","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/(SICI)1097-4644(19960616)61:4%3C514::AID-JCB4%3E3.0.CO;2-R","volume":"61","author":"H Aberle","year":"1996","unstructured":"Aberle H, Schwartz H, Kemler R (1996) Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem 61(4):514\u2013523. https:\/\/doi.org\/10.1002\/(SICI)1097-4644(19960616)61:4%3C514::AID-JCB4%3E3.0.CO;2-R","journal-title":"J Cell Biochem"},{"issue":"5","key":"2343_CR40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/bies.20033","volume":"26","author":"JM Gooding","year":"2004","unstructured":"Gooding JM, Yap KL, Ikura M (2004) The cadherin-catenin complex as a focal point of cell adhesion and signalling: new insights from three-dimensional structures. Bioessays 26(5):497\u2013511. https:\/\/doi.org\/10.1002\/bies.20033","journal-title":"Bioessays"},{"key":"2343_CR41","unstructured":"Vojdani A, Vojdani E (2019) Food-associated autoimmunities: when food turns your immune system against you. In press."},{"issue":"3","key":"2343_CR42","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3892\/etm.2016.3557","volume":"12","author":"L Guo","year":"2016","unstructured":"Guo L, Zhang H, Hou Y, Wei T, Liu J (2016) Plasmalemma vesicle-associated protein: a crucial component of vascular homeostasis. Exp Ther Med 12(3):1639\u20131644. https:\/\/doi.org\/10.3892\/etm.2016.3557","journal-title":"Exp Ther Med"},{"issue":"11","key":"2343_CR43","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/1097-0142(19891201)64:1","volume":"64","author":"GP Bodey","year":"1989","unstructured":"Bodey GP, Elting LS, Rodriquez S, Klebsiella Bacteremia HM (1989) a 10-year review in a cancer institution. Cancer 64(11):2368\u20132376. https:\/\/doi.org\/10.1002\/1097-0142(19891201)64:1","journal-title":"Cancer"},{"issue":"2","key":"2343_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/clinids\/7.2.143","volume":"7","author":"M Garc\u00eda de la Torre","year":"1985","unstructured":"Garc\u00eda de la Torre M, Romero-Vivas J, Mart\u00ednez-Beltr\u00e1n J, Guerrero A, Meseguer M, Bouza E (1985) Klebsiella bacteremia: an analysis of 100 episodes. Rev Infect Dis 7(2):143\u2013150. https:\/\/doi.org\/10.1093\/clinids\/7.2.143","journal-title":"Rev Infect Dis"},{"issue":"3","key":"2343_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0378-1097(90)90085-5","volume":"57","author":"P Williams","year":"1990","unstructured":"Williams P, Ciurana B, Camprubi S, Tomas JM (1990) Influence of lipopolysaccharide chemotype on the interaction between Klebsiella pneumoniae and human polymorphonuclear leucocytes. FEMS Microbiol Lett 57(3):305\u2013309. https:\/\/doi.org\/10.1016\/0378-1097(90)90085-5","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"2343_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/femsre\/fuy043","volume":"43","author":"JA Bengoechea","year":"2019","unstructured":"Bengoechea JA, Sa Pessoa J (2019) Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol Rev 43(2):123\u2013144. https:\/\/doi.org\/10.1093\/femsre\/fuy043","journal-title":"FEMS Microbiol Rev"},{"issue":"3","key":"2343_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.febslet.2012.12.008","volume":"587","author":"AM Costa","year":"2013","unstructured":"Costa AM, Leite M, Seruca R, Figueiredo C (2013) Adherens junctions as targets of microorganisms: a focus on Helicobacter pylori. FEBS Lett 587(3):259\u2013265. https:\/\/doi.org\/10.1016\/j.febslet.2012.12.008 Epub 2012 Dec 19","journal-title":"FEBS Lett"},{"issue":"2","key":"2343_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.yexcr.2008.10.044","volume":"315","author":"E Vikstr\u00f6m","year":"2009","unstructured":"Vikstr\u00f6m E, Bui L, Konradsson P, Magnusson KE (2009) The junctional integrity of epithelial cells is modulated by Pseudomonas aeruginosa quorum sensing molecule through phosphorylation-dependent mechanisms. Exp Cell Res 315(2):313\u2013326. https:\/\/doi.org\/10.1016\/j.yexcr.2008.10.044 Epub 2008 Nov 12","journal-title":"Exp Cell Res"},{"key":"2343_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mib.2016.11.008","volume":"35","author":"A Lubkin","year":"2017","unstructured":"Lubkin A, Torres VJ (2017) Bacteria and endothelial cells: a toxic relationship. Curr Opin Microbiol 35:58\u201363. https:\/\/doi.org\/10.1016\/j.mib.2016.11.008","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"2343_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","volume":"20","author":"JR Dunkelberger","year":"2010","unstructured":"Dunkelberger JR, Song WC (2010) Complement and its role in innate and adaptive immune responses. Cell Res 20(1):34\u201350. https:\/\/doi.org\/10.1038\/cr.2009.139 Epub 2009 Dec 15","journal-title":"Cell Res"},{"key":"2343_CR51","doi-asserted-by":"publisher","unstructured":"Gallego JA, Blanco EA, Morell C, Lencz T, Malhotra AK (2020) Complement component C4 levels in the cerebrospinal fluid and plasma of patients with schizophrenia. Neuropsychopharmacology 22. https:\/\/doi.org\/10.1038\/s41386-020-00867-6 Epub ahead of print","DOI":"10.1038\/s41386-020-00867-6"},{"key":"2343_CR52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbi.2020.08.019","volume":"90","author":"R Rey","year":"2020","unstructured":"Rey R, Suaud-Chagny MF, Bohec AL, Dorey JM, d'Amato T, Tamouza R, Leboyer M (2020) Overexpression of complement component C4 in the dorsolateral prefrontal cortex, parietal cortex, superior temporal gyrus and associative striatum of patients with schizophrenia. Brain Behav Immun 90:216\u2013225. https:\/\/doi.org\/10.1016\/j.bbi.2020.08.019 Epub 2020 Aug 19","journal-title":"Brain Behav Immun"},{"key":"2343_CR53","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3389\/fimmu.2020.02002","volume":"11","author":"TD Purves-Tyson","year":"2020","unstructured":"Purves-Tyson TD, Robinson K, Brown AM, Boerrigter D, Cai HQ, Weissleder C, Owens SJ, Rothmond DA et al (2020) Increased macrophages and C1qA, C3, C4 transcripts in the midbrain of people with schizophrenia. Front Immunol 11:2002. https:\/\/doi.org\/10.3389\/fimmu.2020.02002","journal-title":"Front Immunol"},{"key":"2343_CR54","doi-asserted-by":"crossref","unstructured":"Albert\u00ed S, Marqu\u00e9s G, Camprub\u00ed S, Merino S, Tom\u00e1s JM, Vivanco F, Bened\u00ed VJ (1993) C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect Immun 61(3):852-860. doi: 10.1128\/IAI.61.3.852-860.1993. PMID: 8432605; PMCID: PMC302811.","DOI":"10.1128\/iai.61.3.852-860.1993"},{"issue":"5-6","key":"2343_CR55","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000491439","volume":"10","author":"DAC Heesterbeek","year":"2018","unstructured":"Heesterbeek DAC, Angelier ML, Harrison RA, Rooijakkers SHM (2018) Complement and bacterial infections: from molecular mechanisms to therapeutic applications. J Innate Immun 10(5-6):455\u2013464. https:\/\/doi.org\/10.1159\/000491439","journal-title":"J Innate Immun"},{"key":"2343_CR56","doi-asserted-by":"publisher","unstructured":"Paczosa MK, Mecsas J (2016) Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev 15;80(3):629-661. https:\/\/doi.org\/10.1128\/MMBR.00078-15.","DOI":"10.1128\/MMBR.00078-15"},{"issue":"1","key":"2343_CR57","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00281-017-0662-9","volume":"40","author":"BP Morgan","year":"2018","unstructured":"Morgan BP (2018) Complement in the pathogenesis of Alzheimer\u2019s disease. Semin Immunopathol 40(1):113\u2013124. https:\/\/doi.org\/10.1007\/s00281-017-0662-9","journal-title":"Semin Immunopathol"},{"key":"2343_CR58","doi-asserted-by":"publisher","unstructured":"Eroglu C, Barres BA (2010) Regulation of synaptic connectivity by glia. Nature 11;468(7321):223-231. https:\/\/doi.org\/10.1038\/nature09612.","DOI":"10.1038\/nature09612"},{"issue":"1","key":"2343_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","volume":"57","author":"LA Glantz","year":"2000","unstructured":"Glantz LA, Lewis DA (2000) Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57(1):65\u201373. https:\/\/doi.org\/10.1001\/archpsyc.57.1.65","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2343_CR60","doi-asserted-by":"publisher","first-page":"652","DOI":"10.14336\/AD.2019.0118","volume":"10","author":"K Cho","year":"2019","unstructured":"Cho K (2019) Emerging roles of complement protein C1q in neurodegeneration. Aging Dis 10(3):652\u2013663. https:\/\/doi.org\/10.14336\/AD.2019.0118","journal-title":"Aging Dis"},{"issue":"6286","key":"2343_CR61","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352(6286):712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","journal-title":"Science"},{"key":"2343_CR62","unstructured":"Espinoza LR, Osterland CK (1983) \u201cCirculating immune complexes. Their clinical significance.\u201d Futt, Publishing Co., NY, pp 1-319."},{"issue":"1","key":"2343_CR63","first-page":"18","volume":"43","author":"CK Abrass","year":"1980","unstructured":"Abrass CK, Border WA, Glassock RJ (1980) Circulating immune complexes in rats with autologous immune complex nephritis. Lab Investig 43(1):18\u201327","journal-title":"Lab Investig"},{"issue":"11","key":"2343_CR64","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1681\/ASN.2007080929","volume":"19","author":"A Vizjak","year":"2008","unstructured":"Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, Jurci\u0107 V, Jennette JC (2008) Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 19(11):2237\u20132244. https:\/\/doi.org\/10.1681\/ASN.2007080929","journal-title":"J Am Soc Nephrol"},{"key":"2343_CR65","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fimmu.2019.00504","volume":"10","author":"DV Rizk","year":"2019","unstructured":"Rizk DV, Maillard N, Julian BA, Knoppova B, Green TJ, Novak J, Wyatt RJ (2019) The emerging role of complement proteins as a target for therapy of IgA nephropathy. Front Immunol 10:504. https:\/\/doi.org\/10.3389\/fimmu.2019.00504","journal-title":"Front Immunol"},{"issue":"2","key":"2343_CR66","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5414\/CN107854","volume":"80","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Choi SY, Jeong KH, Sung JY, Moon SK, Moon JY, Lee SH, Lee TW et al (2013) Association of C1q deposition with renal outcomes in IgA nephropathy. Clin Nephrol 80(2):98\u2013104. https:\/\/doi.org\/10.5414\/CN107854","journal-title":"Clin Nephrol"},{"key":"2343_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1092852920001388","volume":"23","author":"AK Matsumoto","year":"2020","unstructured":"Matsumoto AK, Maes M, Supasitthumrong T, Maes A, Michelin AP, de Oliveira SL, de Lima Pedr\u00e3o JV, Moreira EG et al (2020) Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial translocation. CNS Spectr 23:1\u201310. https:\/\/doi.org\/10.1017\/S1092852920001388 Epub ahead of print","journal-title":"CNS Spectr"},{"issue":"1","key":"2343_CR68","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12035-013-8425-7","volume":"48","author":"K Lucas","year":"2013","unstructured":"Lucas K, Maes M (2013) Role of the toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol Neurobiol 48(1):190\u2013204. https:\/\/doi.org\/10.1007\/s12035-013-8425-7","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2343_CR69","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12035-020-02110-1","volume":"58","author":"M Maes","year":"2021","unstructured":"Maes M, Nani JV, Noto C, Rizzo L, Hayashi MAF, Brietzke E (2021) Impairments in peripheral blood T effector and T regulatory lymphocytes in bipolar disorder are associated with staging of illness and anti-cytomegalovirus IgG levels. Mol Neurobiol 58(1):229\u2013242. https:\/\/doi.org\/10.1007\/s12035-020-02110-1 Epub 2020 Sep 11","journal-title":"Mol Neurobiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02343-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02343-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02343-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T14:45:49Z","timestamp":1625496349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02343-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,6]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02343-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,6]]},"assertion":[{"value":"22 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to Thai and international ethics and privacy laws. Approval for the study was obtained from the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (No. 298\/57). All participants and their guardians (parents or other close family members) gave written informed consent prior to participation in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}